Bradley T. Wajda, D.O. PC
(559) 493-5544TMS Therapy Fresno, CA
TMS is a safe, non-invasive treatment for depression. Many people suffering with depression do not respond adequately to prescribed medications. For others, the side effects of taking anti-depressants can be intolerable and even cause serious medical problems. TMS Therapy has been proven and demonstrated to be a very safe and effective new treatment for depression and other disorders.
TMS Therapy is a treatment that is performed in the office without the need for any kind of sedation or anesthesia, using a medical device called the NeuroStar TMS Therapy system.
TMS stands for transcranial magnetic stimulation. It is a noninvasive method of exciting the neurons (nerve cells) in the brain. Your brain is made of nerves. Nerves are shaped like tubes that contain chemicals that move because these chemicals have electrical charges- either positive or negative. By applying a magnetic pulse to the area of the brain that you want to stimulate - it creates an electrical current so that the electrically charged chemicals will move down the pathway or "tube" network that they were designed to follow. This induces the selected area of the brain to work more efficiently, Blood flow and energy rise in the regions of the brain stimulated by TMS. When we apply TMS to the area involved in regulating your mood then we see your mood improve. This safe and non-invasive procedure does not require any anesthesia or sedation. You simply watch a DVD or listen to music and then get up and go about your day. NeuroStar TMS Therapy is an appropriate treatment option for various psychiatric conditions including major depression, anxiety and addiction to name a few.
NeuroStar TMS Therapy is currently FDA-approved for the treatment of depression and there are no systemic side-effects. The absence of side effects using a magnet based on MRI technology makes TMS a great option for pregnant and postpartum women suffering from the debilitating effects of depression. The extent of neonatal risks from the maternal use of psychotropic drugs are still mostly unknown, therefore many doctors recommend that mothers discontinue the use of these medications during pregnancy.
Because TMS is non-systemic and non-invasive, it does not run the risk of negatively affecting the developing fetus or nursing baby.
Follow the video below for more information on the interesting realities and benifits of TMS for Women with Postpartum Depression and Women of Childbearing Years.
*NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. However, Dr. Wajda said it best in a recent interview with "In Focus TV"-
"Who is the 'typical' candidate is somewhat different than who I consider to be the 'best' candidate. The FDA approved TMS for treatment resistant depression- and those numbers are impressive at over 67% having a successful treatment outcome. I see the role of TMS as treating depression at any stage. If it is outperforms medication in treatment resistant depression 67% to 7%- why wait? Even the first antidepressant we try in patients is only successful 27% of the time. How many patients need to avoid medication or medication side effects? This is an ideal choice for depression during pregnancy and into the postpartum period when women breastfeed. Remember, unlike most medication, this is an MRI magnet which is safe for the mother and the baby."- Dr. Wajda
The typical course of treatment for depression consists of 5 treatments per week over a 6 week period- for 30 total treatments. Each treatment session lasts approximately 40 minutes. When treating other "off-label" conditions (illnesses or conditions that have not yet received official FDA approval for TMS therapy) the duration of the treatment will vary.
NeuroStar TMS Therapy is a recent treatment cleared by the US Food and Drug Administration (FDA) for patients suffering from depression who have not achieved satisfactory improvement from prior antidepressant treatment- also known as "Treatment Resistant Depression".
Printed from www.fresnotmstherapy.com/home
Bradley T. Wajda, D.O. PC
1312 W Herndon Ave, Suite 102
Fresno, CA 93711
Phone: (559) 493-5544
Fax: (559) 493-5166